$The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial$

The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial

Abstract We present the rationale for and design of a randomized, open-label, active-control trial comparing the effectiveness of 200 units of onabotulinum toxin A (Botox A®) versus sacral neuromodulation (InterStim®) therapy for refractory urgency urinary incontinence (UUI). The R efractory O verac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Contemporary clinical trials 2014-03, Vol.37 (2), p.272-283
Hauptverfasser:	Amundsen, Cindy L, Richter, Holly E, Menefee, Shawn, Vasavada, Sandip, Rahn, David D, Kenton, Kim, Harvie, Heidi S, Wallace, Dennis, Meikle, Susie
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetylcholine Release Inhibitors - administration & dosage Acetylcholine Release Inhibitors - therapeutic use Adult Aged Botulinum Toxins, Type A - administration & dosage Botulinum Toxins, Type A - economics Botulinum Toxins, Type A - therapeutic use Cardiovascular Cost-Benefit Analysis Female Hematology, Oncology and Palliative Medicine Humans Implantable Neurostimulators Middle Aged Onabotulinum toxin A Pelvic Floor Disorders - therapy Research Design Sacral neuromodulation Urgency urinary incontinence Urinary Bladder, Overactive - therapy Urinary Incontinence, Urge - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!